Miami forward Marcus Allen announced he is cancer-free after seven months of treatment for non-Hodgkin lymphoma, marking a major personal milestone for a player whose first season home with the Hurricanes ended far earlier than anyone expected.
Allen shared the update in an Instagram post on June 30, thanking his family, teammates and supporters who stood with him through chemotherapy. "CANCER FREE!! Nothing but God!" Allen wrote.
Marcus Allen announced on IG that he is now CANCER FREE!
— CanesMuse (@canesmuse) July 1, 2026
What an absolute warrior. We love you @marcusallenn_ ❤️ pic.twitter.com/4W3kHVF6OD
Miami's Marcus Allen delivers the offseason news that matters most
The 6-foot-7 Miami native was diagnosed in December after appearing in eight games during the 2025-26 season. Miami announced on Dec. 19 that Allen would miss the rest of the year and had begun chemotherapy treatment. He averaged 18.9 minutes, 5.3 points and 3.1 rebounds before stepping away from basketball.
Allen's diagnosis came during his first season with the Hurricanes after he transferred home from Missouri. He had played in 26 games as a freshman for the Tigers before Jai Lucas signed him in April of 2025, bringing a former Miami Norland standout back to South Florida. Allen helped Miami Norland win the 2024 FHSAA Class 5A state championship and was a consensus four-star prospect coming out of high school.
Miami's support remained visible throughout the season. Program legend Jack McClinton held a halftime 3-point contest during the Hurricanes' March game against Louisville, with $100 donated to Allen's GoFundMe for every shot McClinton made.
Allen also remained connected to the team while away from the court. He attended Miami's NCAA Tournament run, and he has returned to full practices this offseason as the Hurricanes prepare for the 2026-27 season.
Allen's announcement stands as a sign of perseverance. And Miami now has one of its own back on the path toward the court after a fight that mattered far more than anything basketball related.
